194 related articles for article (PubMed ID: 24771222)
1. The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China.
Sun P; Chen C; Zhang F; An X; Li XY; Li YH; Zhu ZH; Wang FH
Tumour Biol; 2014 Jul; 35(7):7201-8. PubMed ID: 24771222
[TBL] [Abstract][Full Text] [Related]
2. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China.
Sun P; Zhang F; Chen C; Bi X; Yang H; An X; Wang F; Jiang W
Oncotarget; 2016 Jul; 7(27):42650-42660. PubMed ID: 27223088
[TBL] [Abstract][Full Text] [Related]
3. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
[TBL] [Abstract][Full Text] [Related]
4. Relationship between ABO blood group and clinicopathological factors and their effect on the survival of Japanese patients with esophageal squamous cell carcinoma.
Shiratori F; Shimada H; Yajima S; Suzuki T; Oshima Y; Nanami T; Ito M; Kaneko H
Surg Today; 2017 Aug; 47(8):959-965. PubMed ID: 28028639
[TBL] [Abstract][Full Text] [Related]
5. ABO blood group is a predictor of survival in patients with laryngeal cancer.
Jin T; Li PJ; Chen XZ; Hu WH
Chin J Cancer; 2016 Oct; 35(1):90. PubMed ID: 27733208
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439
[TBL] [Abstract][Full Text] [Related]
7. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
Hanprasertpong J; Jiamset I; Atjimakul T
Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
[TBL] [Abstract][Full Text] [Related]
10. Impact of metabolic syndrome on the survival of Chinese patients with resectable esophageal squamous cell carcinoma.
Wen YS; Huang C; Zhang X; Qin R; Lin P; Rong T; Zhang LJ
Dis Esophagus; 2016 Aug; 29(6):607-13. PubMed ID: 26123618
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.
Yang PW; Hsieh MS; Huang YC; Hsieh CY; Chiang TH; Lee JM
PLoS One; 2014; 9(6):e100326. PubMed ID: 24945674
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
13. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy.
Chen YF; Li Q; Chen DT; Pan JH; Chen YH; Wen ZS; Zeng WA
Cancer Biomark; 2016 Jun; 17(1):89-96. PubMed ID: 27314297
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
[TBL] [Abstract][Full Text] [Related]
16. Correlation of ABO blood group with clinicopathologic characteristics of patients with esophageal squamous cell carcinoma.
Nozoe T; Ezaki T; Baba H; Kakeji Y; Maehara Y
Dis Esophagus; 2004; 17(2):146-9. PubMed ID: 15230728
[TBL] [Abstract][Full Text] [Related]
17. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of preoperative serum tumor markers in esophageal squamous cell carcinoma.
Zhao H; Chen W; Wu J; Wang L; Mao W
J Cancer Res Ther; 2014 Nov; 10 Suppl():C179-85. PubMed ID: 25450279
[TBL] [Abstract][Full Text] [Related]
19. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
